Search

Search Constraints

You searched for: Author/Creator Krishnan, Preethi

Search Results

3. Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors. Issue 7 (1st April 2020)

4. Discovery of fluorobenzimidazole HCV NS5A inhibitors. Issue 22 (15th November 2016)

5. Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long‐term follow‐up study. (14th March 2022)

6. Effect of Baseline Resistance‐Associated Variants on SVR with the 3D Regimen with and without RBV in GT1a and GT1b‐Infected Patients: 854. (October 2016)

7. Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis. Issue 8 (6th May 2019)

8. Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial. Issue 10 (October 2017)

9. Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial. Issue 2 (4th January 2018)

10. Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis. Issue 3 (11th December 2018)